NCT06237881 2026-02-18
A Phase 1/2 Study of KSQ-001EX, Autologous Tumor Infiltrating Lymphocytes Engineered to Inactivate the SOCS1 Gene, in Patients With Select Advanced Solid Tumors
M.D. Anderson Cancer Center
Phase 1/2 Active not recruiting
M.D. Anderson Cancer Center
University of California, Davis
AgonOx, Inc.
H. Lee Moffitt Cancer Center and Research Institute
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS